Braintact Company Profile

This profile of BRAINTACT LTD is based on multiple public records. It may contain errors, and certainly contains omissions. You can help fill in the gaps.


EDIT LOGO


Website: EDIT

Basics

Annual revenue: $0 EDIT
Annual profit: EDIT

No. of employees: 0 EDIT

Parent company: BRAINTACT LTD EDIT
Related company names: BRAINTACT LTD EDIT

Top military customer: EDIT
Aggregate value of contracts from top customer in years _:
Number of contracts represented in that total:

Locations

SOURCE EDIT LOCATIONS

People

**

Top owner (individual)**: SOURCE EDIT EDIT MUGSHOT

Top owner (institutional): EDIT

Other owners: EDIT

**

Chief executive: Noa Shelach SOURCE EDIT EDIT MUGSHOT
Chief executive annual compensation**: EDIT

Other executives: EDIT

**

Board chair**: EDIT EDIT MUGSHOT

Other board members: EDIT

**

Top lobbyist**: EDIT EDIT MUGSHOT

Other lobbyists: EDIT

Annual lobbying expenses (average or most recent year): EDIT

**

Top political donee: EDIT EDIT MUGSHOT
Lifetime total given to top donee**:

Other political donees: EDIT

Annual political campaign giving (average or most recent year): EDIT

Associated people: EDIT

Activities

Summary: SOURCE EDIT

Braintact develops a novel drug for the treatment of acute and chronic neurodegenerative disorders based on Prof. TeichbergÕs innovative, patent pending blood glutamate scavenging system.

Original record type: , 2009

Last updated on Feb. 25, 2011 with contributions from WIB.

DOWNLOAD DATA OR ORDER A CUSTOM REPORT ABOUT BRAINTACT LTD